Case Study: 3E helps Merck navigate complex regulatory landscape with speed and accuracy

Overview

Merck is a premier research-intensive biopharmaceutical company pioneering innovative health solutions to advance the prevention and treatment of diseases in people and animals. With an enormous Life Sciences business in North America operating under the name, Millipore Sigma, Merck manages a huge portfolio of approximately 300,000 pharmaceutical and biotechnology products, ranging from solvents, to reagents, traditional laboratory equipment, membranes, filters and more.

Merck’s portfolio of products has grown exponentially since 2000. In addition, the global regulatory landscape has evolved significantly over the last decade, increasing demand for accurate, up-to-date safety data sheets, on demand compliance verification, and complex marketability assessments based on regional regulations.

Merck relies on 3E ERC+ to help them streamline and expedite creation and management of SDS across their expanding product portfolio. They also leverage the tool to provide marketability assessments and impromptu product content queries.